De Lepeleire I - Search Results

1

Characterizing the PK/PD relationship for inhibition of capsaicin-induced dermal vasodilatation by MK-3207, an oral calcitonin gene related peptide receptor antagonist.

Li CC, Vermeersch S, Denney WS, Kennedy WP, Palcza J, Gipson A, Han TH, Blanchard R, De Lepeleire I, Depré M, Murphy MG, Van Dyck K, de Hoon JN. Li CC, et al. Among authors: de lepeleire i, de hoon jn. Br J Clin Pharmacol. 2015 May;79(5):831-7. doi: 10.1111/bcp.12547. Br J Clin Pharmacol. 2015. PMID: 25377933 Free PMC article. Clinical Trial.

2

Plasma drug profiles and tolerability of MK-571 (L-660,711), a leukotriene D4 receptor antagonist, in man.

Depré M, Margolskee DJ, Hsieh JY, Van Hecken A, Buntinx A, De Lepeleire I, Rogers JD, De Schepper PJ. Depré M, et al. Among authors: de lepeleire i, de schepper pj. Eur J Clin Pharmacol. 1992;43(4):427-30. doi: 10.1007/BF02220621. Eur J Clin Pharmacol. 1992. PMID: 1451725 Clinical Trial.

3

Human pharmacokinetics and tolerability of L-697,639, a non-nucleoside HIV-1 reverse transcriptase inhibitor.

Van Hecken A, Depre M, De Lepeleire I, Laskin O, Au T, Woolf E, Yeh KC, De Schepper PJ. Van Hecken A, et al. Among authors: de lepeleire i, de schepper pj. Int J Clin Pharmacol Res. 1994;14(2):45-50. Int J Clin Pharmacol Res. 1994. PMID: 7530697 Clinical Trial.

4

Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men.

Barrett JS, Murphy G, Peerlinck K, De Lepeleire I, Gould RJ, Panebianco D, Hand E, Deckmyn H, Vermylen J, Arnout J. Barrett JS, et al. Among authors: de lepeleire i. Clin Pharmacol Ther. 1994 Oct;56(4):377-88. doi: 10.1038/clpt.1994.152. Clin Pharmacol Ther. 1994. PMID: 7955799 Clinical Trial.

5

Pharmacokinetics and pharmacodynamics of multiple oral doses of MK-0591, a 5-lipoxygenase-activating protein inhibitor.

Depré M, Friedman B, Van Hecken A, de Lepeleire I, Tanaka W, Dallob A, Shingo S, Porras A, Lin C, de Schepper PJ. Depré M, et al. Among authors: de lepeleire i, de schepper pj. Clin Pharmacol Ther. 1994 Jul;56(1):22-30. doi: 10.1038/clpt.1994.96. Clin Pharmacol Ther. 1994. PMID: 8033491 Clinical Trial.

6

Plasma concentrations and effect on testosterone metabolism after single doses of MK-0434, a steroid 5 alpha-reductase inhibitor, in healthy subjects.

Van Hecken A, Depré M, Schwartz JI, Tjandramaga TB, Winchell GA, De Lepeleire I, Ng J, De Schepper PJ. Van Hecken A, et al. Among authors: de lepeleire i, de schepper pj. Eur J Clin Pharmacol. 1994;46(2):123-6. doi: 10.1007/BF00199874. Eur J Clin Pharmacol. 1994. PMID: 8039530

7

Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.

De Lepeleire I, Reiss TF, Rochette F, Botto A, Zhang J, Kundu S, Decramer M. De Lepeleire I, et al. Clin Pharmacol Ther. 1997 Jan;61(1):83-92. doi: 10.1016/S0009-9236(97)90184-3. Clin Pharmacol Ther. 1997. PMID: 9024176 Clinical Trial.

8

Pharmacokinetic and pharmacodynamic interaction between the lipoxygenase inhibitor MK-0591 and the cyclooxygenase inhibitor ibuprofen in man.

Depré M, Van Hecken A, Verbesselt R, De Lepeleire I, Schwartz J, Porras A, Larson P, Lin C, De Schepper PJ. Depré M, et al. Among authors: de lepeleire i, de schepper pj. Int J Clin Pharmacol Res. 1998;18(2):53-61. Int J Clin Pharmacol Res. 1998. PMID: 9675622 Clinical Trial.

9

Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.

Van Hecken A, Depré M, Verbesselt R, Wynants K, De Lepeleire I, Arnout J, Wong PH, Freeman A, Holland S, Gertz B, De Schepper PJ. Van Hecken A, et al. Among authors: de lepeleire i, de schepper pj. J Clin Pharmacol. 1999 May;39(5):495-500. J Clin Pharmacol. 1999. PMID: 10234597 Clinical Trial.

10

Effect of multiple doses of montelukast, a CysLT1 receptor antagonist, on digoxin pharmacokinetics in healthy volunteers.

Depré M, Van Hecken A, Verbesselt R, Wynants K, De Lepeleire I, Freeman A, Holland S, Shahane A, Gertz B, De Schepper PJ. Depré M, et al. Among authors: de lepeleire i, de schepper pj. J Clin Pharmacol. 1999 Sep;39(9):941-4. doi: 10.1177/00912709922008579. J Clin Pharmacol. 1999. PMID: 10471986 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters